The Lee situation has at least one important implication outside of the acquisition itself.
a. The Braves give more in prospect value for Lee in order to take on less of his contract.
b. The Braves give little in prospect value for Lee and take on most of his contract.
If a, the Braves are indeed in a prolonged spending funk that will probably not end.
If b, the Braves have been holding back on spending only because they didn’t see anything worth spending money on.
If this deal goes through, it will go some distance toward answering our lingering suspicions about the spending habits of the organization. In other words, if we give up Delgado, or even Kimbrel, and take on less than half of Lee’s $$$, we’re pretty much broke.
One theme I don’t like about Wren: buying high. I know most would say Lee is a buy-low, but I think his back struggles and plate struggles are pretty well established by now, and that his homer outburst versus the Cards makes this a buy-high in the same vein as Ankiel’s and Gonzalez’s numbers right before they came over.
We bought high on Nate McLouth, Gonzo, Ankiel, Farnsworth, and now Lee.
If we “sold low” on any of our pitching prospects going across for Lee… unhappiness shall flow forth.
Holy smokes. Glaus will rehab in Gwinnett at third base. I don’t like this at all. The whole advantage of having Lee and Glaus is that they can spell one another. I hope it’s just a back up plan and that Infante/Prado close out the season at 2nd/3rd.
I will be livid if Glaus replaces Infante in the starting line up and Omar has to go back to the bench after proving himself again.
I think Glaus is rehabbing at 1st and 3rd for more lineup flexibility. If the Braves were facing a real tough lefty in Sept., then you could sit Heyward and play Omar in LF, Diaz in RF, and Melky in CF. Prado would obviously move back to 2nd. Cox would be able to bat all righties against a lefty pitcher (if Ross plays for mac). We could then use all lefties plus the Venezuelans against right handed pitchers.